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INTRODUCTION
Typhoid fever is an endemic disease in the developing world;
an estimated 16 million cases occur each year resulting in
700,000 deaths (1). An appropriate antibiotics is essential for
the treatment of typhoid fever. Until the mid-1970s chloram-
phenicol was the drug of choice for typhoid fever, and result-
ed in a marked reduction in mortality from 10% to <2% in
developed countries. Unfortunately, a few sporadic isolations
of chloramphenicol-resistant Salmonella enterica serotype Typhi
were reported from Chile and Kuwait before 1970, and multi-
drug resistant S. enterica Typhi emerged in the Indian subcon-
tinent in 1987 (2). After introduction of ciprofloxacin, it is
used extensively for the treatment of typhoid both in the devel-
oping and developed countries. Thus, recent emergence of
S. enterica Typhi isolates with decreased susceptibility to cipro-
floxacin has been gaining worldwide attention (3, 4).
Typhoid fever is one of class 1 notifiable diseases in Korea.
It has decreased remarkably since the mid-1970s, but over
two hundred cases of typhoid fever have still been reported
nationwide each year (5). Ciprofloxacin is recommended as
the drug of choice for typhoid fever since the 1990s. The
epidemiologic features of typhoid fever and the antimicrobial
resistance of the pathogens were expected to change recently
with the improvement of hygiene and widespread use of anti-
microbials in Korea. Thus, we performed this study to char-
acterize the recent epidemiological features of typhoid fever in
Korea, and to analyze the change of antimicrobial suscepti-
bility of S. enterica Typhi isolated nationwide for recent 9 yr.
MATERIALS AND METHODS
Data Collection
A retrospective analysis was performed for the culture-proven
cases nationwide from 1992 to 2000, using the database of
the Korean National Institute of Health (KNIH). Because
typhoid fever is categorized as a class 1 notifiable disease in
Korea, proved cases by culture or clinically suspected cases
of typhoid fever are supposed to be reported from the medi-
cal facilities nationwide. Culture-proven cases were defined
as the patients in which S. enterica Typhi was isolated from any
specimen in a hospital or a public health center or Insitutue
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Epidemiology of Salmonella enterica Serotype Typhi Infections in
Korea for Recent 9 Years: Trends of Antimicrobial Resistance
The aim of this study is to characterize the epidemiological features of typhoid fever,
categorized as class 1 notifiable disease in Korea and to analyze the recent change
of antimicrobial resistance of Salmonella enterica serotype Typhi isolated nationwide.
We retrospectively analyzed the 1,692 culture-proven cases from 1992 to 2000,
using the data of the Korean National Institute of Health. The overall incidence of
culture-proven typhoid fever was 0.41 per 100,000 population. It occurred all over
the country, but the southeastern part of Korean peninsula had the higher incidence
rate than other areas. There were several outbreaks suspected, of which two out-
breaks were confirmed. The resistance rate against chloramphenicol showed mild
increase, but the ampicillin, trimethoprim/sulfamethoxazole, kanamycin, or nalidixic
acid resistance remained at the similar levels for the past 9 yr. There were 21 (1.3%)
multidrug-resistant (MDR) strains isolated since 1992, and the number of those has
increased. Two strains resistant to ciprofloxacin were first identified in Korea.
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of Health & Environment of each province. Clinically suspect-
ed cases were the reported patients which showed the clinical
manifestations of typhoid fever and were reported to the KNIH,
but S. enterica Typhi failed to be isolated from their specimens.
The Laboratory of Enteric Pathogens in KNIH has collected
the demographic data and isolates of the reported cases. Col-
lected isolates were cultured again and analyzed for microbial
characteristics including antibiotic resistance information.
Using these data collected from 1992 to 2000, patient’ s age,
gender, place of residence, date of disease occurrence, Vi phage
type of the bacteria, and antimicrobial susceptibility were stud-
ied.
Antimicrobial Susceptibility Test and Phage Typing
A total of 1,692 isolates were available for this analysis. An-
timicrobial susceptibility tests were available for 1,561 of
1,692 cases. Among 1,561 isolates, 31 strains, all were from
1992, were excluded because of the incomplete data for the
analysis. Thus, a total of 1,530 isolates were studied. S. enter-
ica Typhi isolates were tested for susceptibility to antimicro-
bials by a controlled disk diffusion technique according to the
guidelines provided by the National Committee for Clinical
Laboratory Standards (6). The antibiotic discs contained ampi-
cillin (10  g), kanamycin (30  g), streptomycin (10  g), tetra-
cycline (30  g), chloramphenicol (30  g), trimethoprim/sul-
famethoxazole (SXT-TMP) (1.25/23.75  g), nalidixic acid (30
g), and ciprofloxacin (5  g). Phage typing was performed as
described previously (7), with the phage set provided by the
Central Public Health Laboratory at London, United Kingdom.
Multidrug- resistant (MDR) strains were defined as resis-
tant to ampicillin, chloramphenicol, and SXT-TMP.
Statistical Analysis
Using the population of 1996 as a reference, we estimated
the incidence of culture-proven typhoid fever (/100,000 pop-
ulation/year), and described it by the year, region, seasons, and
personal characteristics such as age and gender. We also com-
pared the numbers of culture-proven cases with the clinical-
ly suspected cases notified to the KNIH. Score test for trend
was used to investigate the trends of resistance rate of several
antimicrobials for the isolates as time passed (8). The SAS
system for Windows (release 6.12, The SAS Institute Inc., Cary,
NC, U.S.A.) was used for all statistical analyses.
RESULTS
Epidemiologic Characteristics
The incidence of culture-proven typhoid fever for recent 9
yr was 0.41 per 100,000 persons per year. Annual rate of inci-
dence varied from 0.23 to 0.80 per 100,000 persons (Table 1).
The number of cases in which the pathogens were proved in
the KNIH was 55.9% of all clinically suspected cases since
1992 (a total of 2,837 cases). The proportions of culture-proven
cases among clinically suspected cases were from 38.7% to
77.2% each year. The incidence, based on the clinically sus-
pected cases, was 0.74 per 100,000 persons per year.
We analyzed the occurrence of culture-proven typhoid fever
by age, gender, regions, and seasons. The infection occurred
most frequently in the age group of forties, followed by the
fifties, thirties, and twenties (Table 2). The incidence of women
was slightly higher than that of men (men, 0.34 per 100,000
persons; women, 0.40). The difference of incidence for the
gender was prominent in the age group of twenties, forties
and fifties.
Table 1 shows the incidence rate of culture-proven typhoid
fever by year and residence of patients. The data showed that
the infection occurred in all over the country, but the south-
eastern part of Korean peninsula, such as Gyeongbuk, Gyeong-
nam, and Busan, had the higher rate of incidence than other
areas. The annual incidence rate of the infection from differ-
City/Prorince
Annual rate of incidence of typhoid fever (per 100,000 populations)
1992 1993 1994 1995 1996 1997 1998 1999 2000 Total
Seoul 0.11 0.16 0.06 0.04 0.05 0.12 0.58 0.19 0.13 0.16
Gangwon 0.46 0.73 0.20 1.08 0.20 0.27 0.54 0.54 0.27 0.48
Gyeonggi 0.36 0.16 0.18 0.16 0.18 0.14 0.38 0.23 0.11 0.21
Gyeongnam 0.24 0.24 0.50 0.62 0.81 0.53 1.04 1.18 0.58 0.64
Gyeongbuk 0.27 0.57 0.72 0.75 0.54 0.42 0.40 0.87 0.85 0.69
Busan 0.29 0.42 0.83 1.48 5.51 0.65 2.04 1.05 0.74 1.44
Jeonnam 0.23 0.67 0.09 0.12 0.15 0.12 0.56 0.32 0.18 0.27
Jeonbuk 0.15 0.00 0.10 0.00 2.55 0.00 0.00 0.05 0.16 0.34
Chungnam 0.36 0.43 0.29 0.03 0.13 0.09 0.12 0.59 0.09 0.24
Chungbuk 0.00 0.07 0.93 0.07 0.07 0.07 0.07 0.14 0.20 0.28
Jeju 0.00 0.00 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.02
Total isolated 0.27 0.29 0.32 0.38 0.80 0.23  0.63  0.40  0.29 0.41
Total notified 0.51 0.74 0.60 0.81 1.05 0.56 0.81 0.66 0.48 0.74
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ent regions showed certain level of fluctuation; those of Seoul
in 1998, Gangwon in 1995, Busan in 1996, Jeonnam in 1993
and 1998, Jeonbuk in 1996, Chungnam in 1999, and Chung-
buk in 1994 showed more than 2-fold of overall incidence rate
in each region for 9 yr. Among them, the epidemic outbreaks
of typhoid fever were confirmed in Busan (9) and Jeonbuk in
1996 (10). This suggests that outbreaks of typhoid fever oc-
curred in many regions although the outbreaks were not no-
ticed.
The incidence of culture-proven typhoid fever showed a
clear seasonal clustering. In most years, the incidence rate was
low in winter (November to February), increased gradually
from March, and reached its peak from April to June (Fig. 1).
However, the incidence rate in summer (July to September)
was unexpectedly low in most years. A very large peak in sum-
mer of 1996 was because of the previously reported outbreak
in Busan (9), and the second small peak in 1996 was also be-
cause of the known outbreak in Jeonbuk (10).
Antimicrobial Susceptibilities
Among 1,530 strains, 595 (44.3%) were isolated from blood
and 724 (54.0%) were isolated from stool. The ratio of the
specimen from which the pathogen was isolated was similar
each year except 1992 and 1999, in which there were more
stool isolates (79.2% and 80.7%, respectively).
Among 1,530 isolates, 617 isolates (40.3%) were resistant
to 1 or more antibiotics, and 21 (1.3%) were multidrug-resis-
tant (MDR) strains, defined as resistant to ampicillin, chlo-
ramphenicol, and SXT-TMP. The overall resistance rate against
chloramphenicol, ampicillin, SXT-TMP, tetracycline, strep-
tomycin, or kanamycin was 5.0%, 3.3%, 1.7%, 8.5%, 34.3%,
or 1.1%, respectively. For 8 yr, the resistance to ampicillin,
SXT-TMP, or kanamycin remained quite stable and the tetra-
cycline resistance was stable except in 1995 (Table 3). How-
ever, the streptomycin resistance showed abrupt drop from
60% before 1997 to 1.4% in 2000. In case of chlorampheni-
col, the increase of resistance rate was statistically significant
as time passed (score test for trend, p<0.05).
The resistance rate of nalidixic acid was 3.1% overall, but
showed a fluctuation up to 6% in 1998 (Table 3). However,
nalidixic acid resistance did not show the significant increase
for recent 8 yr although it had a tendency to increase. It should
be observed further for several years to come. In 1999, two
strains which showed a resistance to ciprofloxacin were isolat-
ed for the first time in Korea. Two isolates showed different
antimicrobial resistance patterns; one was resistant to strep-
Age (yr)
The rate of incidence of typhoid fever
(per 100,000 populations)
Male Female Total
0-9 0.24 0.16 0.20
10-19 0.34 0.33 0.33
20-29 0.29 0.40 0.35
30-39 0.35 0.39 0.37
40-49 0.55 0.78 0.66
50-59 0.40 0.57 0.48
60-69 0.29 0.35 0.33
70- 0.26 0.16 0.20
Total 0.34 0.40 0.37
Table 2. Age- and gender-specific incidence of culture-proven
typhoid fever in Korea (1992-2000)
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Fig. 1. Monthly occurrence of culture-proven typhoid fever for recent
9 yr in Korea. The incidence reached its peak from April to June
every year, and there were two outbreaks confirmed in 1996.
1997
1998
1999
2000
Month
% Resistance 1993 1994 1995 1996 1997 1998 1999 2000 Total
AMP 0.75 4.58 5.85 0.62 9.68 3.11 4.57 0.68 3.31
KM 0 0.76 0 2.16 1.08 0 3.65 0 1.17
SM 47.76 61.07 60.82 50.62 8.6 10.03 27.4 1.36 34.37
SXT-TMP 0.75 0 1.75 0.93 9.68 1.04 3.2 0 1.75
TC 2.99 0 43.86 2.16 10.75 1.73 3.65 2.04 8.45
CM 1.49 0 5.85 2.78 9.68 10.03 6.39 2.04 5.07
NA 0.75 2.29 4.09 1.54 1.08 6.23 2.28 2.04 3.18
AMP, ampicillin; KM, kanamycin; SM, streptomycin; SXT-TMP, trimethoprim-sulfamethoxazole; TC, tetracycline; CM, chloramphenicol; NA, nalidixic acid.
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tomycin and kanamycin, and the other was resistant to SXT-
TMP, ampicillin, streptomycin and kanamycin. But both st-
rains were sensitive to chloramphenicol.
MDR strain resistant to ampicillin, SXT-TMP, and chlo-
ramphenicol was identified in 1992, and the number of MDR
isolates gradually increased thereafter; one in 1992, two in
1995, 8 in 1997, 3 in 1998, and 7 in 1999. The isolates from
1992, 1995, 1997, and 1998 had the same antimicrobial re-
sistance patterns; resistant to ampicillin, chloramphenicol,
streptomycin, tetracycline and SXT-TMP. Six of 7 strains in
1999 were resistant to 5 antimicrobials above and kanamycin.
The strains were identified to contain the resistance plasmid
harboring a novel multidrug resisistance class 1 integron (11).
Regional distribution of these strains isolated in 1999 dispersed
all over the country; two in Gyeonggi, one in Gangwon, Gy-
eongnam, Gyeongbuk, and Chungbuk.
We analyzed the antimicrobial resistance by the specimen
from which the pathogen was isolated and by the region of
occurrence. There was no significant difference of antimicro-
bial resistance according to the specimen. When looking at
the resistance against each antimicrobial by the region of occur-
rence, there was no clear clustering (no data shown). But 8
isolates of MDR S. enterica Typhi were isolated in Gyeonggi
area in 1997 with the same antimicrobial resistance patterns
(resistant to ampicillin, chloramphenicol, streptomycin, SXT-
TMP, and tetracycline) and two bacteriophage types, A or E1.
Phage Typing
Predominant Vi phage types were E1 (23.7%), M1 (18.8%),
untypable (20.8%), and degraded (15.1%). There was con-
siderable diversity in proportion of each phage type year by
year (Fig. 2A). For example, common phage types were
degraded type (37.6%), M1 (24.8%), and E1 (22.7%) in 1995
but E1 (33.5%), untypable (30.6%) and D1 (16.33%) in 1996.
Regional distribution of each phage type was also very diverse
(Fig. 2B). Isolates from Jeonbuk were nearly all D1 (90.6 %).
E1 (39.8%) and untypable (22.8%) were common in isolates
from Busan. However, the proportion of phage type A has a
tendency to increase steadily.
The antimicrobial susceptibility by the phage type was sim-
ilar in most of Vi phage types. It was noted, however, that the
resistance rates against ampicillin (7.9%), chloramphenicol
(19.1%), and nalidixic acid (9.0%) were higher in isolates with
phage type A than overall resistance rates. Among 21 MDR
strains, E1 was most common (9 strains), then phage type A
(4 strains), M1 (3 strains), and untypable (2 strains).
DISCUSSION
Our study provides comprehensive information on the inci-
dence of typhoid fever and antimicrobial resistance of S. enteri-
ca Typhi isolates in Korea. The incidence rate of clinically sus-
pected typhoid fever has been greatly decreased from 10 per
100,000 persons in the 1970s to below 1 per 100,000 persons
in the 1990s as results of improved sanitation and hygiene,
vaccines, and effective antimicrobial chemotherapy in Korea
(12). However, the annual rate of incidence has not been stable
from 0.23 per 100,000 persons to 0.80 in our study based on
the culture-proven cases. If the estimated reporting rate of class
I notifiable disease (71.0%) is applied to total culture-proven
cases (13), the actual incidence rate of typhoid would be 0.58
per 100,000 persons per year in the 1990s.
The southeastern provinces in Korea had a higher incidence
rate of this disease in most years of study. The reason might
be related with contamination of drinking water or the dis-
tribution of chronic carriers. According to the epidemiolog-
ical investigation for a large outbreak in Busan, in 1996, the
source of infection was the tap water supplied through local
pumping station (9). Further investigation is needed to explain
this geographic distribution of typhoid fever.
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Fig. 2. Vi phage types of isolates by time (A) and the region of occurrence (B). There is considerable diversity in proportion of each phage
type by year or region of occurrence. It is noted that the proportion of phage type A has a tendency to increase steadily as times passed.
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Untypable M1 E1 Degraded D1 A B2The analyses of annual incidence rate in a region suggested
that the infection occurred sporadically in most regions and
years. However, although the large outbreaks in Busan and
Jeonbuk were confirmed, smaller-sized outbreaks might be
passed unnoticed. In 1997, 8 MDR strains isolated in Gyeong-
gi area had the same antimicrobial resistance patterns and two
bacteriophage types. This also suggests the spread of the MDR
strains in that area. Thus, the early detection system should
be set up in Korea in order to find out such outbreaks as early
as possible.
The increase of MDR S. enterica Typhi is a great problem
in developing countries. The incidence rates of MDR strains
were 26% in U.K. and 17% in U.S.A., but most infections
have been in patients with a recent history of travel to India
or Pakistan (14, 15). In India, 64.5% of S. enterica Typhi was
MDR in 1993 (16). Recently, S. enterica Typhi with decreased
susceptibility to ciprofloxacin has been increasing worldwide
(15, 17). In 1999, 23% of the strains in U.K. exhibited de-
creased susceptibility to ciprofloxacin, and 60% of the isolates
in India had MIC of 2  g/mL or greater for ciprofloxacin (15,
17). Our data show that MDR S. enterica Typhi strains are not
popular yet in Korea, and the isolates resistant to nalidixic
acid do not seem to be increasing. However, the recent increase
of the number of MDR isolates and emergence of ciprofloxacin
resistance should be concerned. 
Multidrug-resistance was known to be mediated by a large-
sized conjugable plasmids (18-20), and several reports suggest-
ed the international transfer of R-plasmids (19, 20). The pre-
vious pulsed-field gel electrophoresis (PFGE)-based studies
of S. enterica Typhi from southeast Asia demonstrated consid-
erable genetic diversities associated with sporadic cases and
outbreaks, which suggested the movement of MDR strains
within endemic regions (18-22). These findings implicated
that MDR pathogens spread both by clonal spread or trans-
fer of R-plasmid in a society. Further genotypic studies are
needed to analyze the spread of MDR strain in Korea.
In conclusion, although overall incidence of typhoid fever
has not increased significantly since 1992, we noticed the
appearance of S. enterica Typhi resistant to all first-line drugs
used for treatment of typhoid in Korea. Since strains resistant
to ciprofloxacin were also identified, surveillance for resistance
to first-line antibiotics and quinolones should be performed.
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